Taikang Insurance Group’s asset management arm has co-led the second tranche of an $83m round for the autism and speech therapy provider.
China-based autism and speech therapy provider Orient Speech Therapy (OST) has increased its series C funding to $83m with a $60m series C2 round co-led by insurer Taikang Insurance Group, DealStreetAsia has reported.
Singapore state-owned investment firm Temasek co-led the round with Taikang’s Asset Management subsidiary. The series C2 funding follows a $23m series C1 round in February this year led by Cenova Capital that also featured Northern Light Venture Capital and Long Hill Capital.
Founded in 2007, OST offers…
